• Home
  • Clinical
    • Clinical Studies/Trials
    • Congresses and Meetings
    • More…
  • Companies
    • Mergers and Acquisitions
    • Company News
    • Financial
    • More…
  • Specialty
    • Cardio
    • Vascular
    • Orthopaedics
    • Neuro
    • Spine
    • More…
  • News
    • Editorial
    • USA
  • Publish
    • Advertising
    • Contact
  • Home
  • Clinical
    • Clinical Studies/Trials
    • Congresses and Meetings
    • More…
  • Companies
    • Mergers and Acquisitions
    • Company News
    • Financial
    • More…
  • Specialty
    • Cardio
    • Vascular
    • Orthopaedics
    • Neuro
    • Spine
    • More…
  • News
    • Editorial
    • USA
  • Publish
    • Advertising
    • Contact
Medlatest – Medical Device News
medical
device
news

FDA Clears CryoLife’s New HeRO Dialysis Device

CryoLife Receives FDA Clearance For Next Generation HeRO Device (via PR Newswire)

New Adaptor Allows Use with Early Access Arterial Grafts ATLANTA, April 4, 2013 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has received U.S. Food and Drug Administration (FDA) 510…


April 16, 2013 - in: Categories Approval/Clearance, Vascular
linkedin iconLinkedIn
twitter iconTweet
facebook iconShare
whatsapp icon
email iconE-mail

Post navigation

Previous Previous post: CE Mark For Thoracic-Length Heli-FX Aortic Aneurysm Graft System
Next Next post: Boston Scientific Acquires Fixate™ Tissue Band Device
Follow on Twitter Follow @medlatest

Sign up for our Daily Digest email:

* indicates required

Hill Woods Medical Media Logo

Medtech Communications

Medical Device and Lifescience Recruitment
We support the BMA's Medical Fair and Ethical Trade Group's aims
Tweets by medlatest
  • Home
  • Contact
  • About
  • Site Map
  • Privacy
  • Cookies
  • Ts&Cs
  • Copyright
  • Disclaimer
  • Linking
© Medlatest – Medical Device News 2021
∧